Searching across hundreds of databases
Thyroid-associated orbitopathy (TAO) is a disfiguring periocular connective tissue disease associated with autoimmune thyroid disorders. It is a potentially blinding condition, for which no effective pharmacological treatment has been established. Despite a suggested role played by autoimmune thyrotropin receptor activation in the pathogenesis of TAO, the cellular and molecular events contributing to the fibrotic and inflammatory disease process of TAO are not fully defined. By developing a three-dimensional organoid culture of human orbital fibroblasts (OFs), we sought to determine the molecular mechanism underlying the fibrotic disease process of TAO. In this ex vivo model, we have demonstrated that hypoxia-inducible factor (HIF) 2α (HIF2A), but not its paralog HIF1A, accelerates extracellular matrix (ECM) deposition by inducing a collagen-cross-linking enzyme, lysyl oxidase (LOX). Inhibiting HIF2A and LOX with short hairpin RNA or small molecular antagonists effectively ameliorated fibrotic disease process within TAO organoids. Conversely, the overexpression of a constitutively active HIF2A in mouse OFs was sufficient to initiate LOX-dependent fibrotic tissue remodeling in OF organoids. Consistent with these findings, HIF2A and LOX were highly expressed in human TAO tissues paralleling excess ECM deposition. We propose that the HIF2A-LOX pathway can be a potential therapeutic target for the prevention and treatment of TAO.
Pubmed ID: 30388216 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets FN1
View all literature mentionsThis polyclonal targets alpha smooth muscle Actin
View all literature mentionsThis unknown targets Collagen Type III Antibody
View all literature mentionsThis unknown targets COLLAGEN Type I Antibody
View all literature mentionsThis monoclonal targets CTGF (E-5)
View all literature mentionsThis unknown targets
View all literature mentionsThis unknown targets Collagen Type VI Antibody
View all literature mentionsThis unknown targets Mouse IgG (H+L)
View all literature mentionsThis unknown targets Goat Mouse IgG (H L)-HRP Conjugate
View all literature mentionsThis monoclonal targets alpha Tubulin (DM1A)
View all literature mentionsThis monoclonal targets LOX (F-8)
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis recombinant monoclonal targets HIF1-alpha
View all literature mentionsThis monoclonal targets Casp3
View all literature mentionsThis unknown targets
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis unknown targets COLLAGEN Type IV Antibody
View all literature mentionsThis recombinant monoclonal targets HIF2-alpha
View all literature mentionsThis polyclonal targets Ki67 antibody - Proliferation Marker
View all literature mentionsThis unknown targets Goat Mouse IgG (H L)-HRP Conjugate
View all literature mentionsThis monoclonal targets CTGF (E-5)
View all literature mentionsThis polyclonal secondary targets IgG (H+L)
View all literature mentionsThis monoclonal targets alpha Tubulin (DM1A)
View all literature mentionsThis unknown targets
View all literature mentionsThis monoclonal targets Casp3
View all literature mentionsThis polyclonal targets Ki67 antibody - Proliferation Marker
View all literature mentionsThis polyclonal targets alpha smooth muscle Actin
View all literature mentionsThis unknown targets Collagen Type III Antibody
View all literature mentionsThis unknown targets
View all literature mentionsThis unknown targets Mouse IgG (H+L)
View all literature mentionsThis unknown targets Rabbit IgG (H+L)
View all literature mentionsThis monoclonal targets FN1
View all literature mentionsThis recombinant monoclonal targets HIF2-alpha
View all literature mentionsThis unknown targets Collagen Type VI Antibody
View all literature mentionsThis unknown targets COLLAGEN Type IV Antibody
View all literature mentionsThis unknown targets COLLAGEN Type I Antibody
View all literature mentionsThis monoclonal targets LOX (F-8)
View all literature mentionsThis recombinant monoclonal targets HIF1-alpha
View all literature mentionsThe SciCrunch Infrastructure was developed as a cooperative data platform to be used by diverse communities in making data more FAIR.
scicrunch.org
